Ripretinib is a kinase inhibitor used as a pharmaceutical raw material for the manufacturing of advanced gastrointestinal stromal tumor (GIST) therapy. It is indicated for cases that have not adequately responded to other kinase inhibitors such as sunitinib and imatinib.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 1442472-39-0
Nintedanib
kinase inhibitor active pharmaceutical ingredient
(1S,4R)-4-(2-Amino-6-(cyclopropylamino)-7-oxido-9H-purin-9-yl)-2-cyclopentene-1-methanol
Abacavir impurity reference standard
Landiolol hydrochloride
active pharmaceutical ingredient
Carbovir Monophosphate
active pharmaceutical ingredient
Tirofiban
active pharmaceutical ingredient
1-[4-bromo-5-[1-ethyl-7-(methylamino)-2-oxo-1,6-naphthyridin-3-yl]-2-fluorophenyl]-3-phenylurea
CEFJVGZHQAGLHS-UHFFFAOYSA-N
CCN1C2=CC(=NC=C2C=C(C1=O)C3=CC(=C(C=C3Br)F)NC(=O)NC4=CC=CC=C4)NC